Tag : Next

CCT Impact

Full Spectrum Cannabis Extracts Market Expected To Remain Dominant for Next Few Years

CCT IMPACT Agent
Cannabis extracts have gained wide recognition in recent years and are expected to provide impetus to cannabis market growth. Based on product type, cannabis extracts are classified into oils and tinctures. The oils segment is expected to dominate the market in 2019 with a revenue of USD 4.8 billion and is anticipated......
CCT Impact

PAOG CBD RELAX-RX Nutraceutical Plans To Co-Pack With ALKM And Market With USMJ Detailed In Update Scheduled Next Week

CCT IMPACT Agent
PAO Group, Inc. (USOTC: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the company’s CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (USOTC: ALKM) and marketing with North American Cannabis Holdings, Inc. (USOTC: USMJ). CBD RELAX-RX targets......
CCT Impact

Why Blockchain and AI Could Be the Next Game-Changing Technologies for the Cannabis Industry

CCT IMPACT Agent
Artificial Intelligence (AI) and blockchain technologies have already expanded the possibilities of the cannabis industry, especially the delivery market. Using AI to tailor search, product recommendations, and delivery capabilities to individual cannabis customers boosted sales and revenue. The use of chatbots has made finding which strain is right for you a......
CCT Impact

The Next Four Years Could Be Huge For US CBD Companies

CCT IMPACT Agent
Cannabis and hemp stocks have surged in the weeks following President Joe Biden’s electoral victory, and the industry could see some big days ahead under the Biden Administration. Biden vowed ahead of election day to decriminalize cannabis, and there is an expectation in the industry that this will result in a stronger,......
CCT Impact

PAOG Takes Next Step To Produce Cannabis Nutraceuticals

CCT IMPACT Agent
PAO Group, Inc. (USOTC: PAOG) today announced moving forward with its initiative to produce cannabis nutraceuticals. PAOG recently engaged with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care for those experiencing issues associated......
CCT Impact

PAOG Previews Next Acquisition Anticipated In Conjunction With CRO Partnership And CTAP Application

CCT IMPACT Agent
PAO Group, Inc. (USOTC: PAOG) today previewed its next acquisition after just this week closing the acquisition of a cannabis biopharmaceutical asset to treat Chronic Obstructive Pulmonary Disease (COPD) and a cannabis cultivation operation developing a proprietary cannabis cultivar. The COPD treatment, RespRx, is derived from a patented cannabis extraction......